Literature DB >> 19047252

Primary care physician perspectives on reimbursement for childhood immunizations.

Gary L Freed1, Anne E Cowan, Sarah J Clark.   

Abstract

OBJECTIVES: The purpose of this research was to explore physicians' attitudes and behaviors related to vaccine financing issues within their practice. Amid the increasing number of vaccine doses recommended for children and adolescents, anecdotal reports suggest that physicians are facing increasing financial pressures from vaccine purchase and administration and may stop providing vaccines altogether to privately insured children. Whether these sentiments are widely held among immunization providers is unknown.
METHODS: We conducted a cross-sectional mail survey from July to September 2007 of a random sample of 1280 US pediatricians and family physicians engaged in direct patient care. Main outcome measures included delay in the purchase of specific vaccines for financial reasons; reported decrease in profit margin from immunizations; and practice consideration of whether to stop providing all vaccines to privately insured children.
RESULTS: The response rate was 70% for pediatricians and 60% for family physicians. Approximately half of the respondents reported that their practice had delayed the purchase of specific vaccines for financial reasons (49%) and experienced decreased profit margin from immunizations (53%) in the previous 3 years. Twenty-one percent of respondents strongly disagreed that "reimbursement for vaccine purchase is adequate," and 17% strongly disagreed that "reimbursement for vaccine administration is adequate." Eleven percent of respondents said their practice had seriously considered whether to stop providing all vaccines to privately insured children in the previous year.
CONCLUSIONS: Physicians who provide vaccines to children and adolescents report dissatisfaction with reimbursement levels and increasing financial strain from immunizations. Although large-scale withdrawal of immunization providers does not seem to be imminent, efforts to address root causes of financial pressures should be undertaken.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047252     DOI: 10.1542/peds.2008-2033

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City.

Authors:  Susan M Kansagra; Meghan D McGinty; Beth Maldin Morgenthau; Monica L Marquez; Annmarie Rosselli-Fraschilla; Jane R Zucker; Thomas A Farley
Journal:  Am J Public Health       Date:  2011-12-15       Impact factor: 9.308

2.  Hepatitis B vaccination among adolescents 13-17 years, United States, 2006-2012.

Authors:  Peng-jun Lu; David Yankey; Jenny Jeyarajah; Alissa O'Halloran; Laurie Elam-Evans; Stacie M Greby; James A Singleton; Trudy V Murphy
Journal:  Vaccine       Date:  2015-02-25       Impact factor: 3.641

3.  Novel immunization reminder/recall approaches: rural and urban differences in parent perceptions.

Authors:  Alison W Saville; Brenda Beaty; L Miriam Dickinson; Steven Lockhart; Allison Kempe
Journal:  Acad Pediatr       Date:  2014 May-Jun       Impact factor: 3.107

4.  Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.

Authors:  Megan C Lindley; Philip J Smith; Lance E Rodewald
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

5.  Vaccine financing from the perspective of primary care physicians.

Authors:  Sean T O'Leary; Mandy A Allison; Megan C Lindley; Lori A Crane; Laura P Hurley; Michaela Brtnikova; Brenda L Beaty; Christine I Babbel; Andrea Jimenez-Zambrano; Stephen Berman; Allison Kempe
Journal:  Pediatrics       Date:  2014-02-24       Impact factor: 7.124

6.  The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Authors: 
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

7.  Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years.

Authors:  Peng-Jun Lu; David Yankey; Jenny Jeyarajah; Alissa O'Halloran; Sarah A Meyer; Laurie D Elam-Evans; Sarah Reagan-Steiner
Journal:  Am J Prev Med       Date:  2017-05-08       Impact factor: 5.043

8.  To give or not to give: Approaches to early childhood immunization delivery in Oregon rural primary care practices.

Authors:  Lyle J Fagnan; Scott A Shipman; James A Gaudino; Jo Mahler; Andrew L Sussman; Jennifer Holub
Journal:  J Rural Health       Date:  2011-01-11       Impact factor: 4.333

9.  Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008.

Authors:  Charlene A Wong; Zahava Berkowitz; Christina G Dorell; Rebecca Anhang Price; Jennifer Lee; Mona Saraiya
Journal:  Cancer       Date:  2011-06-20       Impact factor: 6.860

10.  Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States.

Authors:  Peng-Jun Lu; David Yankey; Benjamin Fredua; Alissa C O'Halloran; Charnetta Williams; Lauri E Markowitz; Laurie D Elam-Evans
Journal:  J Pediatr       Date:  2018-11-15       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.